• 1
    Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, et al. Guidelines for the medical management of osteoarthritis: part II. osteoarthritis of the knee. Arthritis Rheum 1995; 38: 15416.
  • 2
    Lozada CJ, Altman RD. Management of osteoarthritis. In: KoopmanWJ, editor. Arthritis and allied conditions: a textbook of rheumatology. 14th ed. Baltimore (MD): Lippincott, Williams & Wilkins; 2001. p. 224663.
  • 3
    Pendleton A, Arden N, Dougados M, Doherty M, Bannwarth B, Bijlsma JWJ, et al. EULAR recommendations for therapy of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISITO). Ann Rheum Dis 2000; 59: 93644.
  • 4
    Trease GE, Evans WC, editors. Pharmacognosy. 12th ed. London (UK): Bailliere Tindall; 1983.
  • 5
    Langner ES, Griefenberg S, Gruenwald J. Ingwer: eine Heilpflanze mit Geschichte [Ginger: a medicinal plant with a history]. Balance Z Prax Wiss Komplementarer Ther 1997; 1: 516.
  • 6
    Awang D. Ginger. Can Pharm J 1992: 30911.
  • 7
    Tschirch A. Handbuch der Pharmakognosie [A handbook of pharmacognosy]. Leipzig: Verlag CH Tauchnitz; 1917.
  • 8
    Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T, Riggins W, et al, editors. German Commission E Monographs. Austin (TX): American Botanical Council; 1998.
  • 9
    Blaschek W, Hager H, Hänsel R, Wolf HU, Surmann P, Nyrnberg E, et al. Hager's Handbuch der pharmazeutischen Praxis. 5th rev. ed. Berlin-New York: Springer Verlag; 1990.
  • 10
    Schulick P. Ginger, common spice and wonder drug. 3rd ed. Brattleboro (VT): Herbal Free Press Ltd; 1996.
  • 11
    Swain AR, Duton SP, Truswell AS. Salicylates in foods. J Am Diet Assoc 1985; 85: 95060.
  • 12
    Mustafa T, Srivastava KC, Jensen KB. Drug development: report 9. Pharmacology of ginger, Zingiber officinale. J Drug Dev 1993; 6: 2589.
  • 13
    Kiuchi F, Iwakami S, Shibuya M, Hanaoka F, Sandawa U. Inhibition of prostaglandin and leukotriene biosynthesis by gingeroles and diarylheptanoids. Chem Pharm Bull (Tokyo) 1992; 40: 18791.
  • 14
    Mascolo N, Jain R, Jain SC, Capasso F. Ethnopharmacological investigation of Ginger (Zingiber officinale). J Ethnopharmacol 1989; 27: 12940.
  • 15
    Jana U, Chattopadhayay RN, Shaw BP. Preliminary studies on anti-inflammatory activity of Zingiber officinale Rosc., Vitex negundo Linn. and Tinospora cordifolia (Willid) miers in albino rats. Indian J Pharmacol 1999; 31: 2323.
  • 16
    Rhizoma galangae. Köln: Bundesanzeiger [Federal German Legal Gazette]; 1990 Mar 13. Commission E monograph No.: 173.
  • 17
    Perry L, Metzger J. Medicinal plants of east and southeast Asia: attributed properties and uses. Cambridge (MA): MIT Press; 1980.
  • 18
    Janssen AM, Scheffer JJC. Acetoxychavicol acetate, an antifungal component of Alpinia galanga. Planta Med 1985; 6: 50711.
  • 19
    Itokawa H, Morita H, Sumitomo T, Totsuka N, Takeya K. Antitumor principals from Alpinia galanga. Planta Med 1987; 53: 323.
  • 20
    Substances generally regarded as safe, 21 CFR Section 182.10, 182.20. Washington (DC): GPO; 1998.
  • 21
    Frondoza CG, Frazier C, Polotsky A, Lahiji K, Hungerford DS, Weidner MS. Inhibition of chondrocyte and synoviocyte TNFα expression by hydroxy-alcoxy-phenyl compounds (HAPC) [abstract]. Trans Orthop Res Soc 2000:1038.
  • 22
    Altman RD, Brandt K, Hochberg M, Moskowitz R. Design and conduct of clinical trials in patients with osteoarthritis. Osteoarthritis Cartilage 1996; 4: 21743.
  • 23
    International Conference on Harmonisation. Good clinical practice. Geneva: ICH Secretariat; 1996 May 1. Efficacy Topic: E6.
  • 24
    Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986; 29: 103949.
  • 25
    Kellgren JH, Lawrence JS. Radiological assessment of osteoarthritis. Ann Rheum Dis 1957; 16: 494501.
  • 26
    Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988; 15: 183340.
  • 27
    Ware JE, Kosinski MA, Keller SD. A 12-item Short Form Health Survey. Med Care 1996; 34: 22033.
  • 28
    Adverse reaction terminology. Uppsala: Uppsala Monitoring Centre; 1996.
  • 29
    The 1999 Gallup Trend Study of Attitudes Toward and Use of Herbal Supplements. Princeton, NJ: Multi-sponsor Surveys Inc.; 2000.
  • 30
    Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Rompay M, et al. Trends in alternative medicine use in the United States, 1990–1997. JAMA 1998; 280: 156975.
  • 31
    Srivastava KC, Mustafa T. Ginger (Zingiber officinale) and rheumatic disorders. Med Hypotheses 1989; 29: 258.
  • 32
    Srivastava KC, Mustafa T. Ginger (Zingiber officinale) in rheumatism and musculoskeletal disorders. Med Hypotheses 1992; 39: 3428.
  • 33
    Bliddal H, Rosetzsky A, Schlichting P, Weidner MS, Anderson LA, Ibfelt H, et al. A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis. Osteoarthritis Cartilage 2000; 8: 912.
  • 34
    Bellamy N. WOMAC user's guide. London (Ont): Victoria Hospital Corporation; 1996.
  • 35
    Brater DC. Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition. Am J Med 1999; 107: 6571.
  • 36
    Bjorkman DJ. Nonsteroidal anti-inflammatory drug-induced gastrointestinal injury. Am J Med 1996; 101 Suppl 1A: 2532.
  • 37
    Singh G, Triadafilopoulos G. Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol 1999; 26: 1824.
  • 38
    Al-Yahya MA, Rafatullah S, Mossa JS, Ageel AM, Parmar NS, Tariq M. Gastroprotective activity of ginger zingiber officinal rosc., in albino rats. Am J Chin Med 1989; 17: 516.
  • 39
    Mitsui S, Kobayash S, Nagahori H, Ariba O. Constituents from seeds of Alpinia galanga Wild, and their anti-ulcer activities. Chem Pharm Bull (Tokyo) 1976; 24: 237782.
  • 40
    Groentved A, Brask T, Kambskard J, Hentzer E. Ginger root against seasickness. Acta Otolaryngol 1998; 105: 459.
  • 41
    Bone ME, Wilkinson DJ, Young JR, McNeil J. Ginger root—a new antiemetic: the effect of ginger root on postoperative nausea and vomiting after major gynecological surgery. Anaesthesia 1990; 45: 66971.
  • 42
    Philips S. Zingiber officinale (ginger)—an antiemetic for day case surgery. Anaesthesia 1993; 48: 7157.
  • 43
    Groentved A, Hentzer E. Vertigo-reducing effect of ginger root. J Otorhinolaryngol Relat Spec 1986; 48: 2826.
  • 44
    Miller LG. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 1998; 158: 220011.
  • 45
    Srivastava KC. Effects of aqueous extracts of onion, garlic and ginger on platelet aggregation and metabolism of arachidonic acid in the blood vascular system: in vitro study. Prostaglandins Leukot Med 1984; 13: 22735.
  • 46
    Lumb AB. Effect of dried ginger on human platelet function. Thromb Haemost 1994; 71: 1101.
  • 47
    Janssen PLTMK, Meyboom S, van Staveren WA, de Vegt F, Katan MB. Consumption of ginger (Zingiber officinale Roscoe) does not affect ex vivo platelet thromboxane production in humans. Eur J Clin Nutr 1996; 50: 7724.